Company Overview and News

 
6 Most Undervalued Stocks In Chuck Akre's Portfolio

8h valuewalk
Chuck Akre is an illustrious investor with a 29-year track record and is the founder, chairman and chief investment officer of Akre Capital Management. I take a closer look at Akre’s investment strategy and the firm’s most undervalued stock holdings below.
Upvote Downvote

2
Tracking Charles Akre's Akre Capital Management Portfolio - Q4 2017 Update

2018-02-26 seekingalpha
The top three positions are American Tower, Moody’s, and Mastercard and they add up to ~37% of the entire portfolio.
Upvote Downvote

 
Enstar Group Closes Transaction With Neon, Boosts Portfolio

2018-02-20 zacks
Enstar Group Limited’s Lloyd managing agency, StarStone Underwriting Limited, completed the previously announced reinsurance-to-close transaction with Neon Underwriting Limited for Enstar Group’s Syndicate 2008. The closure of this transaction is expected to help Enstar Group’s Syndicate 2008 undertake the liabilities of the 2015 underwriting year of Neon’s Syndicate 2468 (which comprised underwriting years starting from 2008 to 2015).
Upvote Downvote

 
ESGR / Enstar Group Limited / AKRE CAPITAL MANAGEMENT LLC - 3G (Passive Investment)

2018-02-15 sec.gov
Schedule 13G   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Enstar Group LTD. (Name of Issuer) Common Stock, $1.00 par value (Title of Class of Securities) 028643918 (CUSIP Number) Charles T. Akre, Jr., 2 West Marshall Street, PO Box 998, Middleburg, Virginia 20118-0998, 540.687.3880 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 31, 2017
Upvote Downvote

 
ESGR / Enstar Group Limited / AKRE CAPITAL MANAGEMENT LLC - 3G (Passive Investment)

2018-02-15 sec.gov
Schedule 13G   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Enstar Group LTD. (Name of Issuer) Common Stock, $1.00 par value (Title of Class of Securities) 028643918 (CUSIP Number) Charles T. Akre, Jr., 2 West Marshall Street, PO Box 998, Middleburg, Virginia 20118-0998, 540.687.3880 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 31, 2017
Upvote Downvote

 
ECC / Eagle Point Credit Company Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-02-15 fintel.io
Eagle Point Credit Company Inc. (NYSE:ECC) has 29 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 12,517,730 shares. Largest shareholders include Stone Point Capital Llc, Enstar Group LTD, Mycio Wealth Partners, Llc, Karpus Management, Inc., Freestone Capital Holdings, LLC, Manufacturers Life Insurance Company, The, Pnc Financial Services Group, Inc.
Upvote Downvote

 
ESGR / Enstar Group Limited / FMR LLC / Fidelity - 3G (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 0 ENSTAR GROUP LTD COMMON STOCK Cusip #G3075P101 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #G3075P101 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 31,982 Item 6: 0 Item 7: 975,509 Item 8: 0 Item 9: 975,509 Item 11: 5.939% Item 12: HC Cusip #G3075P101 Item 1: Reporting Person - Abigail P.
Upvote Downvote

 
ESGR / Enstar Group Limited / FMR LLC / Fidelity - 3G (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 0 ENSTAR GROUP LTD COMMON STOCK Cusip #G3075P101 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #G3075P101 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 31,982 Item 6: 0 Item 7: 975,509 Item 8: 0 Item 9: 975,509 Item 11: 5.939% Item 12: HC Cusip #G3075P101 Item 1: Reporting Person - Abigail P.
Upvote Downvote

 
ESGR / Enstar Group Limited 8-K (Current Report)

2018-02-08 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 2, 2018 Enstar Group Limited (Exact name of registrant as specified in its charter) Bermuda   001-33289   N/A (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.
Upvote Downvote

 
BRIEF-Enstar To Acquire Full Ownership Of KaylaRe

2018-02-05 reuters
* ENSTAR GROUP LTD - ‍HILLHOUSE AND STONE POINT WILL EXCHANGE THEIR RESPECTIVE 44% AND 8% SHAREHOLDINGS IN KAYLARE FOR ENSTAR SHARES​
Upvote Downvote

 
BRIEF-Enstar To Acquire Full Ownership Of Kaylare

2018-02-05 reuters
* ENSTAR GROUP LTD - SIGNED AN AGREEMENT TO ACQUIRE A FURTHER 52% STAKE IN KAYLARE HOLDINGS LTD, PARENT COMPANY OF KAYLARE LTD
Upvote Downvote

 
ESGR / Enstar Group Limited S-3/A

2018-01-05 sec.gov
Document As filed with the Securities and Exchange Commission on January 5, 2018   Registration No. 333-220889      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   AMENDMENT NO. 2 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933   ENSTAR GROUP LIMITED (Exact name of registrant as specified in its charter)   Bermuda   N/A (State or other jurisdiction of incorporation or organization)   (I.
Upvote Downvote

 
ESGR / Enstar Group Limited 8-K (Current Report)

2018-01-04 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 28, 2017 Enstar Group Limited (Exact name of registrant as specified in its charter) Bermuda   001-33289   N/A (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.
Upvote Downvote

 
Haynesville Shale Play Sees Decline in Natural Gas Rigs

2018-01-03 zacks
In its weekly release, Houston-based oilfield services player Baker Hughes, a GE company (BHGE - Free Report) , reported a decrease in total rig counts in the United States.  
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: G3075P101